Cargando…
Prognostic impact of reduced HER2 protein expression in post-neoadjuvant therapy resection specimens: A single institution experience and review of the literature
BACKGROUND: Retesting for Human epidermal growth factor receptor-2 (HER2) in post-neoadjuvant therapy resection is variable, and data is conflicting regarding the prognostic significance of changes in HER2 expression pre and post therapy. METHODS: We identified 104 patients with localized HER2 IHC 3...
Autores principales: | Mogica, Jan Paredes, Tang, Haiming, Liang, Yuanxin, Zhong, Minghao, Hui, Pei, Harigopal, Malini, Krishnamurti, Uma, Fischbach, Neal A., Zhan, Haiying |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10568274/ https://www.ncbi.nlm.nih.gov/pubmed/37812963 http://dx.doi.org/10.1016/j.breast.2023.103586 |
Ejemplares similares
-
HER2 testing on core needle biopsy specimens from primary breast cancers: interobserver reproducibility and concordance with surgically resected specimens
por: Tsuda, Hitoshi, et al.
Publicado: (2010) -
Neoadjuvant study of niraparib in patients with HER2-negative, BRCA-mutated, resectable breast cancer
por: Spring, Laura M., et al.
Publicado: (2022) -
What does absence of lymph node in resected specimen mean after neoadjuvant chemoradiation for rectal cancer
por: Lee, Won-Suk, et al.
Publicado: (2013) -
Ideal number of biopsy tumor fragments for predicting HER2 status in gastric carcinoma resection specimens
por: Ahn, Sangjeong, et al.
Publicado: (2015) -
Comparison of HER2 and Phospho-HER2 Expression between Biopsy and Resected Breast Cancer Specimens Using a Quantitative Assessment Method
por: Bai, Yalai, et al.
Publicado: (2013)